Edition:
United States

Oasmia Pharmaceutical AB (OASM.OQ)

OASM.OQ on NASDAQ Stock Exchange Capital Market

0.97USD
11 Dec 2017
Change (% chg)

-- (--)
Prev Close
$0.97
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
1,861
52-wk High
$3.70
52-wk Low
$0.80

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Julian Aleksov

52 2017 Executive Chairman of the Board

Mikael Asp

55 2015 Chief Executive Officer

Anders Blom

48 2017 Acting Chief Financial Officer, Executive Vice President

Magdalena Berg

Head of Accounting

Dzianis Babrou

Head of Product Development